Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07X OTHER NERVOUS SYSTEM DRUGS
N07XX Other nervous system drugs
N07XX02 Riluzole
D00775 Riluzole (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Amyotrophic Lateral Sclerosis (ALS) Agents
Riluzole
D00775 Riluzole (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D00775 Riluzole (JAN/USP/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
D00775 Riluzole
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), non-NMDA
GRIA
D00775 Riluzole (JAN/USP/INN) <JP/US>
GRIK
D00775 Riluzole (JAN/USP/INN) <JP/US>
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D00775 Riluzole (JAN/USP/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00775
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00775